These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34139251)

  • 1. Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration.
    Soerensen SJC; Thomas IC; Schmidt B; Daskivich TJ; Skolarus TA; Jackson C; Osborne TF; Chertow GM; Brooks JD; Rehkopf DH; Leppert JT
    Urology; 2021 Sep; 155():70-76. PubMed ID: 34139251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer.
    Daskivich TJ; Thomas IC; Luu M; Shelton JB; Makarov DV; Skolarus TA; Leppert JT
    J Urol; 2019 Sep; 202(3):518-524. PubMed ID: 31009286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration.
    Sohlberg EM; Thomas IC; Yang J; Kapphahn K; Daskivich TJ; Skolarus TA; Shelton JB; Makarov DV; Bergman J; Bang CK; Goldstein MK; Wagner TH; Brooks JD; Desai M; Leppert JT
    Urol Oncol; 2020 Sep; 38(9):734.e1-734.e10. PubMed ID: 32674954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Age Adjusted Comorbidity Index to Predict Long-Term, Other Cause Mortality in Men with Prostate Cancer.
    Daskivich TJ; Kwan L; Dash A; Saigal C; Litwin MS
    J Urol; 2015 Jul; 194(1):73-8. PubMed ID: 25623745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival among men with conservatively treated localized prostate cancer.
    Albertsen PC; Fryback DG; Storer BE; Kolon TF; Fine J
    JAMA; 1995 Aug 23-30; 274(8):626-31. PubMed ID: 7637143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer.
    Daskivich TJ; Lai J; Dick AW; Setodji CM; Hanley JM; Litwin MS; Saigal C;
    Cancer; 2014 Dec; 120(23):3642-50. PubMed ID: 25042117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.
    Daskivich TJ; Kwan L; Dash A; Greenfield S; Litwin MS
    Eur Urol; 2014 Dec; 66(6):1002-9. PubMed ID: 24924554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.
    Justice AC; Tate JP; Howland F; Gaziano JM; Kelley MJ; McMahon B; Haiman C; Wadia R; Madduri R; Danciu I; Leppert JT; Leapman MS; Thurtle D; Gnanapragasam VJ
    Eur Urol Oncol; 2024 Aug; 7(4):923-932. PubMed ID: 38171965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort.
    Vaculik K; Luu M; Howard LE; Aronson W; Terris M; Kane C; Amling C; Cooperberg M; Freedland SJ; Daskivich TJ
    JAMA Netw Open; 2021 Jun; 4(6):e2112214. PubMed ID: 34081138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer.
    Naser-Tavakolian A; Venkataramana A; Spiegel B; Almario C; Kokorowski P; Freedland SJ; Anger JT; Leppert JT; Daskivich TJ
    Urol Oncol; 2023 Apr; 41(4):205.e1-205.e10. PubMed ID: 36737259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of the National Comprehensive Cancer Network
    Daskivich TJ; Wood LN; Skarecky D; Ahlering T; Freedland S
    J Urol; 2017 Feb; 197(2):356-362. PubMed ID: 27582436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.
    Sammon JD; Abdollah F; D'Amico A; Gettman M; Haese A; Suardi N; Vickers A; Trinh QD
    Eur Urol; 2015 Nov; 68(5):756-65. PubMed ID: 25819724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Reported vs Claims Based Measures of Health for Modeling Life Expectancy in Men with Prostate Cancer.
    Tan HJ; Zhou X; Spratte BN; McMahon S; Nielsen ME; Lund J; Harris AHS; Smith AB; Basch E
    J Urol; 2021 Feb; 205(2):434-440. PubMed ID: 32909877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
    Cooperberg MR; Broering JM; Carroll PR
    J Natl Cancer Inst; 2009 Jun; 101(12):878-87. PubMed ID: 19509351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
    Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
    JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
    Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
    Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of comorbidity on survival among men with localized prostate cancer.
    Albertsen PC; Moore DF; Shih W; Lin Y; Li H; Lu-Yao GL
    J Clin Oncol; 2011 Apr; 29(10):1335-41. PubMed ID: 21357791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved prediction of long-term, other cause mortality in men with prostate cancer.
    Daskivich TJ; Chamie K; Kwan L; Labo J; Dash A; Greenfield S; Litwin MS
    J Urol; 2011 Nov; 186(5):1868-73. PubMed ID: 21944092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
    Patel DN; Jha S; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Chapin BF; Freedland SJ
    Int J Urol; 2018 Dec; 25(12):998-1004. PubMed ID: 30253446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
    Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
    J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.